RIV Capital Inc., a company involved in the areas of cannabis acquisition and investment, has recently announced a $150 million strategic investment by The Hawthorne Collective, a newly-formed cannabis-focused subsidiary of The Scotts Miracle-Gro Company. According to reports, both companies have signed definitive agreements to formalize the purchase of a $150 million unsecured convertible promissory note from RIV Capital.
Under the terms of the investment agreement, RIV Capital is established as the preferred and priority vehicle of The Hawthorne Collective for all investments that are not currently within the scope of The Hawthorne Gardening Company. It appears that, for the time being, RIV Capital’s previously disclosed acquisition plans remain the same, which are based on investing, launching and/or developing US assets in order to build a multi-state cannabis branding and operating platform.
“As we approach the launch of our U.S. platform, we are pleased to announce the strategic investment of The Hawthorne Collective, a subsidiary of one of the largest and most successful companies serving both the CPG and cannabis sectors,” said Narbé Alexandrian, president and CEO, RIV Capital. “The Investment opens up opportunities for considerable value creation and growth for RIV Capital, including potential access to additional capital that will accelerate the growth of our platform. With Scotts Miracle-Gro’s strong track record, reputation and brand recognition, we can leverage lessons learned in the Canadian and U.S. cannabis markets and leverage their expertise to optimize our acquisition and investment strategy.”
Scotts Miracle-Gro has more than six years of experience as a key ancillary supplier to the U.S. cannabis industry, which has given it sufficient knowledge and vast experience in the country’s cannabis sector. Its The Hawthorne Gardening Company subsidiary has now decided to inject significant capital into RIV Capital, which intends to use for legal and general corporate purposes, and will pave the way for potential access to capital that will accelerate the launch and expansion of its US cannabis operation and brand platform.